Methotrexate vs Mirvetuximab Soravtansine
Methotrexate vs Mirvetuximab Soravtansine: Overview
This comparison examines the pharmacological differences between Methotrexate and Mirvetuximab Soravtansine.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Mirvetuximab Soravtansine β Antibody drug conjugate.